Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis

MLA

Namita Tundia, et al. “Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis.” Advances in Therapy, vol. 38, no. 5, Mar. 2021, pp. 2750–56. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d6374afe43834fb54f15a52ff1d70154&authtype=sso&custid=ns315887.

APA

Namita Tundia, Ruta Sawant, Ella X Du, Keith A. Betts, Yan Song, Patrick Tang, Janet E. Pope, & Cynthia Z. Qi. (2021). Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis. Advances in Therapy, 38(5), 2750–2756.

Chicago

Namita Tundia, Ruta Sawant, Ella X Du, Keith A. Betts, Yan Song, Patrick Tang, Janet E. Pope, and Cynthia Z. Qi. 2021. “Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis.” Advances in Therapy 38 (5): 2750–56. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d6374afe43834fb54f15a52ff1d70154&authtype=sso&custid=ns315887.